Literature DB >> 28827384

SAP and Lessons Learned from a Primary Immunodeficiency.

Jennifer L Cannons1, Pamela L Schwartzberg2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28827384      PMCID： PMC5582946          DOI： 10.4049/jimmunol.1701007

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  48 in total

1.  Defective B cell responses in the absence of SH2D1A.

Authors:  Massimo Morra; Robert A Barrington; Ana C Abadia-Molina; Susumo Okamoto; Aimee Julien; Charles Gullo; Anuj Kalsy; Matthew J Edwards; Gang Chen; Rosanne Spolski; Warren J Leonard; Brigitte T Huber; Persephone Borrow; Christine A Biron; Abhay R Satoskar; Michael C Carroll; Cox Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

2.  Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Authors:  Philipp Eissmann; Lisa Beauchamp; Joe Wooters; John C Tilton; Eric O Long; Carsten Watzl
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

3.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

Review 4.  The role of SAP and the SLAM family in autoimmunity.

Authors:  Alice Y Chan; Jill M Westcott; Jill M Mooney; Edward K Wakeland; John D Schatzle
Journal:  Curr Opin Immunol       Date:  2006-09-29       Impact factor: 7.486

5.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.

Authors:  S G Tangye; S Lazetic; E Woollatt; G R Sutherland; L L Lanier; J H Phillips
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes.

Authors:  Ana-Claudia Rocha-Campos; Rahma Melki; Ren Zhu; Nathalie Deruytter; Diane Damotte; Michel Dy; André Herbelin; Henri-Jean Garchon
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

7.  Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.

Authors:  S G Tangye; J H Phillips; L L Lanier; K E Nichols
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

8.  Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.

Authors:  S C Li; G Gish; D Yang; A J Coffey; J D Forman-Kay; I Ernberg; L E Kay; T Pawson
Journal:  Curr Biol       Date:  1999-12-02       Impact factor: 10.834

Review 9.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

10.  SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation.

Authors:  Jennifer L Cannons; Li J Yu; Dragana Jankovic; Shane Crotty; Reiko Horai; Martha Kirby; Stacie Anderson; Allen W Cheever; Alan Sher; Pamela L Schwartzberg
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307
View more
  4 in total

Review 1.  X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.

Authors:  Neelam Panchal; Claire Booth; Jennifer L Cannons; Pamela L Schwartzberg
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 2.  Cell Versus Cytokine - Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity.

Authors:  Oliver Wegehaupt; Katharina Wustrau; Kai Lehmberg; Stephan Ehl
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

3.  A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

Authors:  Irbaz Bin Riaz; Warda Faridi; Mrinal M Patnaik; Roshini S Abraham
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 4.  Measles immunity and immunosuppression.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-09-04       Impact factor: 7.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.